Magdalena Claeson

Goeteborg, O, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Type 2 diabetes in patients with melanoma: a potential prognostic risk factor?

Type 2 diabetes in patients with melanoma: a potential prognostic risk factor?

Journal: The British journal of dermatology

Published: April 25, 2026

Impact of occult metastasis size on mortality in stage IIIA melanoma: a Swedish population-based registry study.

Impact of occult metastasis size on mortality in stage IIIA melanoma: a Swedish population-based registry study.

Journal: The British journal of dermatology

Published: April 19, 2026

Assessment of high- and low-risk histopathologic subtypes of basal cell carcinoma using artificial intelligence and dermatologist evaluation.

Assessment of high- and low-risk histopathologic subtypes of basal cell carcinoma using artificial intelligence and dermatologist evaluation.

Journal: JAAD international

Published: March 29, 2026

Comment on 'Contrasting Survival Outcomes and Patient Characteristics in 5,815 Patients with Stage II and III Melanoma: A Nationwide Population-Based Registry Study from Sweden': reply from authors.

Comment on 'Contrasting Survival Outcomes and Patient Characteristics in 5,815 Patients with Stage II and III Melanoma: A Nationwide Population-Based Registry Study from Sweden': reply from authors.

Journal: The British journal of dermatology

Published: February 13, 2026

Assessing differentiation in cutaneous squamous cell carcinoma: A machine learning approach.

Assessing differentiation in cutaneous squamous cell carcinoma: A machine learning approach.

Journal: JAAD international

Published: December 22, 2025

Simulated daylight versus conventional PDT for mild to moderate actinic keratoses: A randomized controlled trial.

Simulated daylight versus conventional PDT for mild to moderate actinic keratoses: A randomized controlled trial.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: November 04, 2025

Contrasting survival outcomes and patient characteristics in 5815 patients with stage II and III melanoma: a nationwide population-based registry study from Sweden.

Contrasting survival outcomes and patient characteristics in 5815 patients with stage II and III melanoma: a nationwide population-based registry study from Sweden.

Journal: The British journal of dermatology

Published: May 28, 2025

Wise or wide (WoW) study protocol: a national, multicentre, prospective, randomised and controlled, parallel group, non-inferiority study to compare single-staged versus two-staged excisions of thin invasive (≤1.0 mm) melanoma.

Wise or wide (WoW) study protocol: a national, multicentre, prospective, randomised and controlled, parallel group, non-inferiority study to compare single-staged versus two-staged excisions of thin invasive (≤1.0 mm) melanoma.

Journal: BMJ open

Published: April 03, 2025

Simulated daylight vs. conventional PDT for clinical superficial BCC: A randomized controlled trial.

Simulated daylight vs. conventional PDT for clinical superficial BCC: A randomized controlled trial.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: September 06, 2024

Exploring Patient Pain Experiences during and after Conventional Red Light and Simulated Daylight Photodynamic Therapy for Actinic Keratosis: A Qualitative Interview Study.

Exploring Patient Pain Experiences during and after Conventional Red Light and Simulated Daylight Photodynamic Therapy for Actinic Keratosis: A Qualitative Interview Study.

Journal: Acta dermato-venereologica

Published: December 12, 2023

pSTAT5 is associated with improved survival in patients with thick or ulcerated primary cutaneous melanoma.

pSTAT5 is associated with improved survival in patients with thick or ulcerated primary cutaneous melanoma.

Journal: Melanoma research

Published: October 27, 2023

Real-world data show improved melanoma survival in Sweden.

Real-world data show improved melanoma survival in Sweden.

Journal: The British journal of dermatology

Published: August 18, 2023

Showing 1-12 of 30

Last Updated: 09/26/2026